Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study-Reference-Cited by-同舟云学术

Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study

Published:2014-01-14 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

van de Laar Rafli,Zusterzeel Petra LM,Van Gorp Toon,Buist Marrije R,van Driel Willemien J,Gaarenstroom Katja N,Arts Henriette JG,van Huisseling Johannes CM,Hermans Ralph HM,Pijnenborg Johanna MA,Schutter Eltjo MJ,Pelikan Harold MP,Vollebergh Jos HA,Engelen Mirjam JA,IntHout Joanna,Kruitwagen Roy FPM,Massuger Leon FAG

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-22.pdf

Reference13 articles.

1. Ledermann JA, Raja FA: Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer. Eur J Cancer. 2011, 47: S104-S115.

2. Parmar MK, Ledermann JA, Colombo N, du Bois A, Delaloye JF, Kristensen GB, Wheeler S, Swart AM, Qian W, Torri V, et al: Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet. 2003, 361 (9375): 2099-2106.

3. Pfisterer J, Vergote I, Du Bois A, Eisenhauer E: Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer. Int J Gynecol Cancer. 2005, 15 (Suppl 1): 36-41.

4. Aghajanian C, Blank SV, Goff BA, Judson PL, Teneriello MG, Husain A, Sovak MA, Yi J, Nycum LR: OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol. 2012, 30 (17): 2039-2045. 10.1200/JCO.2012.42.0505.

5. Bristow RE, Puri I, Chi DS: Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol Oncol. 2009, 112 (1): 265-274. 10.1016/j.ygyno.2008.08.033.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary Cytoreductive Surgery in Relapsed Platinum-Sensitive Epithelial Ovarian Cancer: A Systematic Review of Randomized Controlled Trials;Cancers;2024-07-22

2. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial);Annals of Surgical Oncology;2023-12-15

3. Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes;Cancers;2022-12-06

4. Is there a role for secondary debulking in ovarian cancer? A review of the current literature;Current Opinion in Obstetrics & Gynecology;2022-10-13

5. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer;Cochrane Database of Systematic Reviews;2022-08-30